文献速递脊柱脊髓外科

血清蛋白生物标志物用于退行性颈髓病:一项前瞻性研究

Serum protein biomarkers for degenerative cervical myelopathy: a prospective study.
PubMed 文献 · J Neurosurg Spine · 2025-04-11

前瞻性纳入20例临床诊断退行性颈髓病(DCM)并计划行减压手术的患者,术前及术后3个月量化血清神经元和炎症蛋白,并与10例健康对照比较。术前神经丝轻链(NfL)和白细胞介素(IL)-6在DCM患者中显著高于对照,NfL、IL-6和脑源性神经营养因子(BDNF)对区分DCM与对照最佳。术前NfL与术后捏力改善显著相关,炎症标志物与颈痛相关残疾和上肢功能改善相关。

要点

  • 术前血清NfL和IL-6在DCM患者中显著高于健康对照。
  • 术前NfL、IL-6和BDNF对区分DCM与对照最佳。
  • 术前NfL与术后捏力改善显著相关。

核心结论

  • 术前血清NfL、IL-6和BDNF显示出作为DCM诊断标志物的潜力。
  • 术前神经元损伤和炎症的血清生物标志物可预测DCM术后早期功能结局。

研究设计与样本

  • 前瞻性研究,纳入2022年7月至2023年8月临床诊断DCM并计划行减压手术的患者20例,健康对照10例。
  • 术前及术后3个月量化血清神经元和炎症蛋白,并与功能指标关联。

主要发现

  • DCM患者中位年龄70岁,健康对照中位年龄65岁。
  • 术前NfL在DCM患者为30.2 pg/ml vs 健康对照11.2 pg/ml(p=0.01),DCM患者显著高于对照。
  • 术前IL-6在DCM患者为2.9 vs 健康对照1.2(p=0.003),DCM患者显著高于对照。
  • 术前NfL、IL-6和BDNF对区分DCM与对照最佳(p<0.001)。
  • 术后3个月血清BDNF(p=0.001)、淀粉样蛋白β42(p=0.042)和肿瘤坏死因子α(p=0.007)较术前显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delays in diagnosis are common in degenerative cervical myelopathy (DCM), and there is a need for additional objective assessments of spinal cord structure and function. The objective of this study was to profile serum protein biomarkers in DCM and determine their potential diagnostic and prognostic utility. METHODS: Patients with clinically diagnosed DCM (n = 20) and scheduled to undergo decompressive surgery were prospectively enrolled from July 2022 to August 2023. Serum neuronal and inflammatory proteins in the patients were quantified before surgery and 3 months after surgery. Serum protein levels were compared between the DCM patients and healthy controls (n = 10). Serum biomarkers were also related to pre- and postsurgical functional measures. RESULTS: DCM patients had a median age of 70 years, and healthy controls had a median age of 65 years. Presurgical neurofilament light chain (NfL; 30.2 vs 11.2 pg/ml, p = 0.01) and interleukin (IL)-6 (2.9 vs 1.2, p = 0.003) were significantly higher in DCM patients than in controls. Presurgical NfL, IL-6, and brain-derived neurotrophic factor (BDNF) best differentiated DCM and controls (p < 0.001). At 3 months after surgery, serum BDNF (p = 0.001), amyloid beta 42 (p = 0.042), and tumor necrosis factor alpha (p = 0.007) were significantly increased compared to presurgical values. Presurgical serum NfL was significantly associated with improvement in pinch strength after surgery (p = 0.03). Inflammatory biomarkers were linked to improvement in the neck pain-related disability and upper limb function. CONCLUSIONS: Presurgical serum levels of NfL, IL-6, and BDNF show potential as diagnostic markers for DCM. Presurgical serum biomarkers of neuronal damage and inflammation predict early postsurgical functional outcomes in DCM.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Vedantam A, Rahman M, Salam S, et al. Serum protein biomarkers for degenerative cervical myelopathy: a prospective study. J Neurosurg Spine. 2025. PMID: 40215624. doi:10.3171/2025.1.SPINE241085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。